CD93 and cancer: As Pax5 deficiency alone is sufficient to render pro-B cells susceptible to myeloid differentiation14, we concluded that cancer uses M-CSF to reduce expression of Pax5 in CSF1R+CD93+ BMBP and thereby promote macrophage differentiation.